Despite Bio-Techne's high P/E ratio, the lower forecast grow...

Despite Bio-Techne's high P/E ratio, the lower forecast growth potentially overvalues it. Investors may risk a share price decline due to weak earnings outlook, posing a risk for those holding onto shares.